{
  "page_number": 37,
  "text": " \n \n32 \n \n*\"Time zero\" or \"time of presentation\" is defined as the time of triage in the emergency department \nor, if presenting from another healthcare facility, from the earliest time-point in the treatment chart \nwherein, the patient had all the features consistent with sepsis. \n**Two or more sets of blood cultures are recommended before initiation of any new antimicrobial in \nall patients with suspected sepsis. \n***Hydroxyethyl starches (HESs) are not recommended for intravascular volume replacement in \npatients with sepsis or septic shock. \n**** Norepinephrine is the first-choice vasopressor. \n \nReferences: \n1. Guarino M, Perna B, Cesaro AE, et al. 2023 Update on Sepsis and Septic Shock in Adult Patients: \nManagement in the Emergency Department. J Clin Med. 2023;12(9):3188. Published 2023 Apr 28. \ndoi:10.3390/jcm12093188 \n2. Treatment Guidelines for Antimicrobial Use in Common Syndromes. 2nd edition. ICMR. 2019. \nNew \nDelhi \n(Accessed \non \n2nd \nApril, \n2025). \nAvailable \nfrom:  \nhttps://www.icmr.gov.in/icmrobject/custom_data/pdf/resource-\nguidelines/Treatment_Guidelines_2019_Final.pdf \n3. Harris PNA, Tambyah PA, Lye DC, Mo Y, Lee TH, Yilmaz M, Alenazi TH, Arabi Y, Falcone M, Bassetti \nM, Righi E, Rogers BA, Kanj S, Bhally H, Iredell J, Mendelson M, Boyles TH, Looke D, Miyakis S, \nWalls G, Al Khamis M, Zikri A, Crowe A, Ingram P, Daneman N, Griffin P, Athan E, Lorenc P, Baker \nP, Roberts L, Beatson SA, Peleg AY, Harris-Brown T, Paterson DL; MERINO Trial Investigators and \nthe Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN). Effect of \nPiperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients with E coli or Klebsiella \npneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial. \nJAMA. 2018 Sep 11;320(10):984-994. doi: 10.1001/jama.2018.12163. Erratum in: JAMA. 2019 Jun \n18;321(23):2370. doi: 10.1001/jama.2019.6706. PMID: 30208454; PMCID: PMC6143100. \n \n",
  "tables": [],
  "italic_text": [
    "*\"Time zero\" or \"time of presentation\" is defined as the time of triage in the emergency department",
    "or, if presenting from another healthcare facility, from the earliest time-point in the treatment chart",
    "wherein, the patient had all the features consistent with sepsis.",
    "**Two or more sets of blood cultures are recommended before initiation of any new antimicrobial in",
    "all patients with suspected sepsis.",
    "***Hydroxyethyl starches (HESs) are not recommended for intravascular volume replacement in",
    "patients with sepsis or septic shock.",
    "**** Norepinephrine is the first-choice vasopressor.",
    "J Clin Med",
    "E coli"
  ],
  "dimensions": {
    "width": 595.3200073242188,
    "height": 841.9199829101562
  }
}